Three distinct signals are colliding on CF this week. Analysts are divided on direction. Short sellers are pressing harder. Options traders are buying protection at the fastest pace in two weeks.
Rothschild & Co upgraded CF Industries from Sell to Neutral on Monday, raising its price target to $110 from $98. That upgrade lands while the stock trades at $114.67 — above the new target. Analyst Mazahir Mammadli is essentially saying the sell case is spent, but not that buyers should be rewarded here.
Bernstein took the other side just one day later. James Hooper initiated coverage at Outperform with a $162 target — a 41% premium to current levels. Keybanc's Salvator Tiano sits in the middle, initiating at Underweight with a $115 target.
Three new analyst positions. Three different conclusions. That dispersion matters.
Short interest hit 6.1% of free float as of September 25. That's up 21% over the past month and 12.6% over the past week. The one-week jump is the standout — 9.5 million shares short, up from roughly 8.5 million in late August.
The borrow market remains loose. Availability sits at 1,288% — more than 13 shares available for every one already borrowed. Cost to borrow is just 0.42%, down 29% on the week. Short sellers are adding exposure freely. There's no friction stopping them.
The put-call ratio reached 0.88 on September 25. That's 2.45 standard deviations above its 20-day mean of 0.81. The z-score is the highest in two weeks.
CF fell 10% over the past week and nearly 10% over the past month. Options traders are paying up for downside protection as the stock slides. The 52-week PCR range runs from 0.44 to 1.83 — so at 0.88, protection-buying is elevated but not extreme.
The bear case rests on two structural concerns. First, a potential increase in Chinese urea exports could undermine CF's pricing power heading into the second half of 2026. Second, new ammonia supply entering the US Gulf region could pressure nitrogen margins precisely when seasonal demand weakens.
The stock's EV/EBITDA sits at 6.9x, down roughly 0.4x over the past week as the price dropped. The mean analyst price target is $127, still 11% above Friday's close. But that consensus hides the three-way analyst split laid out above.
See the live data behind this article on ORTEX.
Open CF on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
